2025 ACCP Annual Meeting Highlights: NMBA & Ketamine

2025 ACCP Annual Meeting Highlights: NMBA & Ketamine

From Pharmacy to Dose: The Critical Care Podcast by Nick Peters

October 20, 2025 · 1h 5m

About this episode

The episode highlights key education sessions from the 2025 ACCP Annual Meeting focusing on Neuromuscular Blocking Agents and Ketamine.

2025 ACCP Annual Meeting Highlights: Neuromuscular Blocking Agents & Ketamine Highlighting two education sessions from the 2025 ACCP Annual Meeting in today’s daily recap. 01:25 – Neuromuscular Blocking Agents in the Critical Care Setting Featuring: Scott Benken, PharmD, MHPE, FCCP, FCCM, BCCCP, BCPS Megan Rech, PharmD, Masters in Research, FCCP, FCCM, BCCCP Julie DiBridge Clarkson, PharmD, BCCCP, BCCP, BCPS Eric Johnson, PharmD, MBA, BCCCP 39:50 – Use of Ketamine Across Multiple Practice Areas Featuring: Leslie Hamilton, PharmD, FCCP, BCCCP, BCPS David Zimmerman, PharmD, FASHP, FCCP, BCCCP, BCEMP https://www.accp.com/meetings/am25/index.aspx @Pharmacytodose Pharmacytodose@gmail.com Learn more about your ad choices. Visit megaphone.fm/adchoices

People in this episode

Host: Nick Peters

Guests: Scott Benken, PharmD, MHPE, FCCP, FCCM, BCCCP, BCPS, Megan Rech, PharmD, Masters in Research, FCCP, FCCM, BCCCP, Julie DiBridge Clarkson, PharmD, BCCCP, BCCP, BCPS, Eric Johnson, PharmD, MBA, BCCCP, Leslie Hamilton, PharmD, FCCP, BCCCP, BCPS, David Zimmerman, PharmD, FASHP, FCCP, BCCCP, BCEMP, Scott Benken, Megan Rech, Julie DiBridge Clarkson, Eric Johnson, Leslie Hamilton, David Zimmerman

Topics covered

  • Neuromuscular Blocking Agents
  • Ketamine
  • Critical Care
  • Pharmacy Education
  • ACCP Annual Meeting

Keywords

  • ACCP Annual Meeting
  • Neuromuscular Blocking Agents
  • Ketamine
  • Critical Care Pharmacy
  • Pharmacy Education

Mentioned in this episode

Organizations: ACCP

More episodes of Pharmacy to Dose: The Critical Care Podcast

Explore listener stats, chart rankings, contacts and more on the Pharmacy to Dose: The Critical Care Podcast podcast page.